Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Shanghai Junshi Biosciences (1877 HK)
Watchlist
209
Analysis
Health Care
•
China
Shanghai Junshi Biosciences Co., Ltd. operates as a biopharmaceutical company. The Company develops and sells small molecule drugs, antibody drug conjugates, and other products. Shanghai Junshi Biosciences markets its products worldwide.
more
Watchlist
Filings
Presentations
Events
Refresh
Exchange Announcement •
26 Jul 2024 21:42
Inside Information - Receipt Of A Positive Opinion From The Committee For Medicinal Products For Human Use Of The European Medicines Agency For Toripalimab
Attachment
Exchange Announcement •
17 Jul 2024 20:35
Voluntary Announcement - Acceptance Of The Supplemental New Drug Application For Toripalimab In Combination With Bevacizumab For The First-Line Treatment Of Advanced Hepatocellular Carcinoma
Attachment
Exchange Announcement •
10 Jul 2024 21:09
Voluntary Announcement - Wholly-Owned Subsidiary Obtaining The Eu Gmp Certificate
Attachment
Exchange Announcement •
09 Jul 2024 21:22
Voluntary Announcement - Js125 Received The Acceptance Notice For The Investigational New Drug Application
Attachment
Exchange Announcement •
25 Jun 2024 20:49
Voluntary Announcement - Approval Of The Supplemental New Drug Application For Toripalimab For The First-Line Treatment Of Advanced Tnbc
Attachment
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.34.2
x